首页 > 最新文献

Postgraduate medicine最新文献

英文 中文
Clinical features and management strategies of acute soluble barium poisoning: a review of case reports. 急性可溶性钡中毒的临床特点及处理策略:病例报告回顾。
Pub Date : 2025-06-01 Epub Date: 2025-05-29 DOI: 10.1080/00325481.2025.2511340
Jiacheng Wu, Zhenning Liu

Soluble barium salts including barium carbonate, nitrate, acetate, and chloride are commonly used in the manufacture of ceramics, insecticides, and rodenticides. Soluble barium salts are highly toxic to humans if ingested. Acute soluble barium poisoning is an uncommon but life-threatening problem. The fatal dose of barium chloride for man has been reported to be only 0.8 to 0.9 gram. Currently, there have been no systematic studies on acute soluble barium poisoning. Based on the retrospective analysis of 55 global cases, toxicological characteristics, clinical features and management of acute soluble barium poisoning were summarized. Barium is a competitive blocker of potassium inward rectifier channels to inhibit K+ efflux, resulting in profound hypokalemia. Acute soluble barium poisoning can result in gastrointestinal effects including vomiting and diarrhea, followed by hemodynamic disturbances, cardiac arrhythmias, muscle weakness, and cardiac arrest. Respiratory failure induced by muscle paralysis is the major cause of death. Management strategies mainly include prevention of barium absorption, administration of soluble sulfates, potassium supplementation, antiarrhythmic medications, hemodialysis/CVVHDF, and cardiorespiratory support. Timely administration of decontamination and correction of hypokalemia are the two important points. This narrative review will offer crucial information for treating patients with acute soluble barium poisoning.

可溶性钡盐包括碳酸钡、硝酸钡、醋酸钡和氯化物,通常用于制造陶瓷、杀虫剂和灭鼠剂。可溶性钡盐如果摄入人体是剧毒的。急性可溶性钡中毒是一种罕见但危及生命的疾病。据报道,氯化钡对人体的致死剂量仅为0.8至0.9克。目前还没有关于急性可溶性钡中毒的系统研究。通过对55例急性可溶性钡中毒病例的回顾性分析,总结急性可溶性钡中毒的毒理学特点、临床特点及处理方法。钡是钾向内整流通道的竞争性阻滞剂,可抑制K+外排,导致深度低钾血症。急性可溶性钡中毒可导致胃肠道反应,包括呕吐和腹泻,随后是血流动力学紊乱、心律失常、肌肉无力和心脏骤停。由肌肉麻痹引起的呼吸衰竭是死亡的主要原因。治疗策略主要包括预防钡吸收、可溶性硫酸盐管理、补充钾、抗心律失常药物、血液透析/CVVHDF和心肺支持。及时给药净化和纠正低钾血症是两个重点。本文将为急性可溶性钡中毒患者的治疗提供重要信息。
{"title":"Clinical features and management strategies of acute soluble barium poisoning: a review of case reports.","authors":"Jiacheng Wu, Zhenning Liu","doi":"10.1080/00325481.2025.2511340","DOIUrl":"10.1080/00325481.2025.2511340","url":null,"abstract":"<p><p>Soluble barium salts including barium carbonate, nitrate, acetate, and chloride are commonly used in the manufacture of ceramics, insecticides, and rodenticides. Soluble barium salts are highly toxic to humans if ingested. Acute soluble barium poisoning is an uncommon but life-threatening problem. The fatal dose of barium chloride for man has been reported to be only 0.8 to 0.9 gram. Currently, there have been no systematic studies on acute soluble barium poisoning. Based on the retrospective analysis of 55 global cases, toxicological characteristics, clinical features and management of acute soluble barium poisoning were summarized. Barium is a competitive blocker of potassium inward rectifier channels to inhibit K<sup>+</sup> efflux, resulting in profound hypokalemia. Acute soluble barium poisoning can result in gastrointestinal effects including vomiting and diarrhea, followed by hemodynamic disturbances, cardiac arrhythmias, muscle weakness, and cardiac arrest. Respiratory failure induced by muscle paralysis is the major cause of death. Management strategies mainly include prevention of barium absorption, administration of soluble sulfates, potassium supplementation, antiarrhythmic medications, hemodialysis/CVVHDF, and cardiorespiratory support. Timely administration of decontamination and correction of hypokalemia are the two important points. This narrative review will offer crucial information for treating patients with acute soluble barium poisoning.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"338-343"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144133355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newborn screening programs promote vaccine acceptance among parents in Turkey: a cross-sectional study. 新生儿筛查项目促进了土耳其父母对疫苗的接受:一项横断面研究。
Pub Date : 2025-06-01 Epub Date: 2025-05-15 DOI: 10.1080/00325481.2025.2504866
İzzet Erdal, Ayça Burcu Kahraman, Yılmaz Yıldız, Siddika Songül Yalçın
<p><strong>Objectives: </strong>Newborn screening and childhood immunization are among the most successful public health initiatives. Turkey has a high vaccination coverage (95-99%), but a recent decline is concerning. Vaccine hesitancy (VH) is a growing global issue, identified by the WHO as a major public health threat. Given that VH may correlate with attitudes toward other health practices, we explored whether early engagement with the health system via newborn screening influences childhood vaccine acceptance. Although these programs are implemented separately but concurrently as part of the national healthcare system in Turkey, integrating newborn screening and immunization initiatives may increase vaccine uptake through early engagement and trust building. This study aims to evaluate the relationship between newborn screening and parental vaccine hesitancy.</p><p><strong>Methods: </strong>This study was conducted at a tertiary care center in Turkey from July 2023 to April 2024. Parental VH was assessed using the PACV scale, along with questions on demographics and parental vaccination status. Participants with PACV score ≥ 50 were classified as VH+, others as VH-. Groups were compared using t-tests, Mann - Whitney U, chi-squared, or Fisher's exact tests. Multiple logistic regression was used to analyze related factors.</p><p><strong>Results: </strong>This analytic descriptive study included 481 parents (125 with children diagnosed with biotinidase deficiency or PKU via newborn screening, and 356 with healthy children aged 2-6). The mean age of respondents was 35 years, and the majority were mothers with a college education. The main sources of vaccine information were health professionals, followed by social media and family. Overall, 19.8% of parents were vaccine-hesitant, with a lower rate in the patient group (12% vs. 22.5%). VH was higher in fathers with chronic diseases (35.1% vs 18.1%, <i>p</i> = .012) and was lower in mothers received tetanus vaccine during pregnancy (16.1% vs. 30.6%, <i>p</i> = .001) or parents who received COVID-19 vaccine (mothers: 13.9% vs. 50.6%, fathers: 14.8% vs. 49.2%, both <i>p</i> < .001). VH was lower in those consulting healthcare professionals and higher in those relying on social media or non-medical sources. Diagnosis and treatment through newborn screening had an effect of 0.47 odds on VH in the overall group (95% CI = 0.24-0.92, <i>p</i> = .028).</p><p><strong>Conclusion: </strong>This study found lower vaccine hesitancy among participants in newborn screening programs and those whose parents received adult vaccinations, potentially due to increased contact with health professionals and greater health-seeking behavior. The influence of social media on vaccine hesitancy, evident in the general population, was not observed among cases, suggesting that systematic follow-up may buffer against external risk factors. Studies with matched cohorts, real-time data collection, and anonymous surveys are needed
目标:新生儿筛查和儿童免疫是最成功的公共卫生举措。土耳其的疫苗接种率很高(95-99%),但最近的下降令人担忧。疫苗犹豫(VH)是一个日益严重的全球问题,被世界卫生组织确定为一个主要的公共卫生威胁。鉴于VH可能与对其他卫生做法的态度有关,我们探讨了通过新生儿筛查早期参与卫生系统是否会影响儿童接受疫苗。虽然这些规划是单独实施的,但作为土耳其国家卫生保健系统的一部分同时实施,将新生儿筛查和免疫倡议结合起来,可以通过早期参与和建立信任来增加疫苗的吸收率。本研究旨在评估新生儿筛查与父母疫苗犹豫之间的关系。方法:本研究于2023年7月至2024年4月在土耳其的一家三级保健中心进行。使用PACV量表评估父母的VH,同时询问人口统计学和父母的疫苗接种状况。PACV评分≥50的参与者分为VH+组,其余分为VH-组。组间比较采用t检验、Mann - Whitney U检验、卡方检验或Fisher精确检验。采用多元logistic回归分析相关因素。结果:这项描述性分析研究纳入了481名父母(125名通过新生儿筛查诊断为生物素酶缺乏症或PKU的儿童,356名2-6岁的健康儿童)。受访者的平均年龄为35岁,大多数是受过大学教育的母亲。疫苗信息的主要来源是卫生专业人员,其次是社交媒体和家庭。总体而言,19.8%的父母对疫苗犹豫不决,患者组的比例较低(12%对22.5%)。患有慢性疾病的父亲的VH较高(35.1%对18.1%,p = 0.012),而在怀孕期间接种破伤风疫苗的母亲(16.1%对30.6%,p = .001)或接种COVID-19疫苗的父母(母亲:13.9%对50.6%,父亲:14.8%对49.2%,p = 0.028)中VH较低。结论:本研究发现,在新生儿筛查项目的参与者和父母接受成人疫苗接种的参与者中,疫苗犹豫率较低,这可能是由于与卫生专业人员的接触增加和更大的求医行为。社交媒体对疫苗犹豫的影响在一般人群中很明显,但在病例中没有观察到,这表明系统的随访可以缓冲外部风险因素。需要匹配队列、实时数据收集和匿名调查的研究来提高概括性、支持因果推理和减少偏差。
{"title":"Newborn screening programs promote vaccine acceptance among parents in Turkey: a cross-sectional study.","authors":"İzzet Erdal, Ayça Burcu Kahraman, Yılmaz Yıldız, Siddika Songül Yalçın","doi":"10.1080/00325481.2025.2504866","DOIUrl":"10.1080/00325481.2025.2504866","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;Newborn screening and childhood immunization are among the most successful public health initiatives. Turkey has a high vaccination coverage (95-99%), but a recent decline is concerning. Vaccine hesitancy (VH) is a growing global issue, identified by the WHO as a major public health threat. Given that VH may correlate with attitudes toward other health practices, we explored whether early engagement with the health system via newborn screening influences childhood vaccine acceptance. Although these programs are implemented separately but concurrently as part of the national healthcare system in Turkey, integrating newborn screening and immunization initiatives may increase vaccine uptake through early engagement and trust building. This study aims to evaluate the relationship between newborn screening and parental vaccine hesitancy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study was conducted at a tertiary care center in Turkey from July 2023 to April 2024. Parental VH was assessed using the PACV scale, along with questions on demographics and parental vaccination status. Participants with PACV score ≥ 50 were classified as VH+, others as VH-. Groups were compared using t-tests, Mann - Whitney U, chi-squared, or Fisher's exact tests. Multiple logistic regression was used to analyze related factors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;This analytic descriptive study included 481 parents (125 with children diagnosed with biotinidase deficiency or PKU via newborn screening, and 356 with healthy children aged 2-6). The mean age of respondents was 35 years, and the majority were mothers with a college education. The main sources of vaccine information were health professionals, followed by social media and family. Overall, 19.8% of parents were vaccine-hesitant, with a lower rate in the patient group (12% vs. 22.5%). VH was higher in fathers with chronic diseases (35.1% vs 18.1%, &lt;i&gt;p&lt;/i&gt; = .012) and was lower in mothers received tetanus vaccine during pregnancy (16.1% vs. 30.6%, &lt;i&gt;p&lt;/i&gt; = .001) or parents who received COVID-19 vaccine (mothers: 13.9% vs. 50.6%, fathers: 14.8% vs. 49.2%, both &lt;i&gt;p&lt;/i&gt; &lt; .001). VH was lower in those consulting healthcare professionals and higher in those relying on social media or non-medical sources. Diagnosis and treatment through newborn screening had an effect of 0.47 odds on VH in the overall group (95% CI = 0.24-0.92, &lt;i&gt;p&lt;/i&gt; = .028).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study found lower vaccine hesitancy among participants in newborn screening programs and those whose parents received adult vaccinations, potentially due to increased contact with health professionals and greater health-seeking behavior. The influence of social media on vaccine hesitancy, evident in the general population, was not observed among cases, suggesting that systematic follow-up may buffer against external risk factors. Studies with matched cohorts, real-time data collection, and anonymous surveys are needed","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"423-438"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144046808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment burden and its impact on residual cardiovascular risk in community-dwelling older adults with cardiometabolic multimorbidity: an exploratory cross-sectional study. 治疗负担及其对社区老年心血管代谢多病患者剩余心血管风险的影响:一项探索性横断面研究
Pub Date : 2025-06-01 Epub Date: 2025-05-28 DOI: 10.1080/00325481.2025.2510894
Yang Gao, Yang Li, Ying Zhang, Hua Jiang

Background and aims: Cardiometabolic multimorbidity (CMM), defined as ≥ 2 coexisting cardiometabol ic diseases, contributes significantly to global disease burden in older adults. Treatment burden and inflammation-related residual cardiovascular risk in this population remain poorly characterized. This study aimed to quantify treatment burden in community-dwelling older adults with CMM and explore its association with inflammatory indicators.

Methods: A random sample of 170 CMM patients (age ≥60 years) from a Shanghai community completed questionnaires, such as the Treatment Burden Questionnaire (TBQ), and underwent laboratory tests. The participants were stratified according to their treatment burden and then compared in terms of demographics, lifestyle, number of cardiometabolic diseases, medication usage, and cardiometabolic and inflammatory indicators (monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII)). Linear regression models and restricted cubic splines were employed to examine the associations of treatment burden with inflammatory indicators.

Results: Among participants, 37.65% (64/170) reported high treatment burden (TBQ >59). The high TBQ group exhibited poorer medication adherence (39.06% vs. 24.53%) and higher inflammatory indicators (MLR: 0.24 vs. 0.19; NLR: 1.86 vs. 1.43; SII: 352.55 vs. 276.26). No significant differences were observed in cardiometabolic indicators (except for creatinine) or medication counts. Each 10-point TBQ increase was associated with higher MLR (β = 0.01), NLR (β = 0.11), and SII (β = 18.76) in adjusted models. Non-linear associations were observed between TBQ and NLR/SII.

Conclusion: Over one-third of elderly CMM patients experience high treatment burden linked to inflammation-driven residual cardiovascular risk. Early treatment burden assessment and anti-inflammatory strategies may improve their prognosis in primary care.

背景和目的:心脏代谢多病(CMM),定义为≥2种并存的心脏代谢疾病,对老年人的全球疾病负担有重要影响。在这一人群中,治疗负担和炎症相关的剩余心血管风险的特征仍然很差。本研究旨在量化社区居住的老年慢性粒细胞白血病患者的治疗负担,并探讨其与炎症指标的关系。方法:随机抽取上海市某社区年龄≥60岁的慢性mm患者170例,填写治疗负担问卷(TBQ),并进行实验室检查。根据治疗负担对参与者进行分层,然后根据人口统计学,生活方式,心脏代谢疾病数量,药物使用以及心脏代谢和炎症指标(单核细胞与淋巴细胞比率(MLR),中性粒细胞与淋巴细胞比率(NLR)和全身免疫炎症指数(SII))进行比较。采用线性回归模型和限制三次样条来检查治疗负担与炎症指标的关系。结果:在参与者中,37.65%(64/170)报告高治疗负担(TBQ bbb59)。高TBQ组药物依从性较差(39.06%比24.53%),炎症指标较高(MLR: 0.24比0.19;NLR: 1.86比1.43;SII: 352.55 vs 276.26)。在心脏代谢指标(肌酐除外)或药物计数方面没有观察到显著差异。在调整后的模型中,TBQ每增加10点,MLR (β = 0.01)、NLR (β = 0.11)和SII (β = 18.76)均升高。TBQ与NLR/SII呈非线性相关。结论:超过三分之一的老年CMM患者经历与炎症驱动的残余心血管风险相关的高治疗负担。早期治疗负担评估和抗炎策略可改善初级保健患者的预后。
{"title":"Treatment burden and its impact on residual cardiovascular risk in community-dwelling older adults with cardiometabolic multimorbidity: an exploratory cross-sectional study.","authors":"Yang Gao, Yang Li, Ying Zhang, Hua Jiang","doi":"10.1080/00325481.2025.2510894","DOIUrl":"10.1080/00325481.2025.2510894","url":null,"abstract":"<p><strong>Background and aims: </strong>Cardiometabolic multimorbidity (CMM), defined as ≥ 2 coexisting cardiometabol ic diseases, contributes significantly to global disease burden in older adults. Treatment burden and inflammation-related residual cardiovascular risk in this population remain poorly characterized. This study aimed to quantify treatment burden in community-dwelling older adults with CMM and explore its association with inflammatory indicators.</p><p><strong>Methods: </strong>A random sample of 170 CMM patients (age ≥60 years) from a Shanghai community completed questionnaires, such as the Treatment Burden Questionnaire (TBQ), and underwent laboratory tests. The participants were stratified according to their treatment burden and then compared in terms of demographics, lifestyle, number of cardiometabolic diseases, medication usage, and cardiometabolic and inflammatory indicators (monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII)). Linear regression models and restricted cubic splines were employed to examine the associations of treatment burden with inflammatory indicators.</p><p><strong>Results: </strong>Among participants, 37.65% (64/170) reported high treatment burden (TBQ >59). The high TBQ group exhibited poorer medication adherence (39.06% vs. 24.53%) and higher inflammatory indicators (MLR: 0.24 vs. 0.19; NLR: 1.86 vs. 1.43; SII: 352.55 vs. 276.26). No significant differences were observed in cardiometabolic indicators (except for creatinine) or medication counts. Each 10-point TBQ increase was associated with higher MLR (β = 0.01), NLR (β = 0.11), and SII (β = 18.76) in adjusted models. Non-linear associations were observed between TBQ and NLR/SII.</p><p><strong>Conclusion: </strong>Over one-third of elderly CMM patients experience high treatment burden linked to inflammation-driven residual cardiovascular risk. Early treatment burden assessment and anti-inflammatory strategies may improve their prognosis in primary care.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"396-403"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of relative fat mass to estimate prevalent prehypertension and hypertension in the general population. 相对脂肪量对估计普通人群中普遍存在的高血压前期和高血压的意义。
Pub Date : 2025-06-01 Epub Date: 2025-05-08 DOI: 10.1080/00325481.2025.2502317
Shan Li, Zhi Du, Heng Chen, Liding Zhao, Pei Zhou, Xuan Zhang, Safraz Anwar, Jialan Lv, Zhicheng Pan, Xiaogang Guo

Objective: To evaluate the relationship between relative fat mass (RFM) with prehypertension and hypertension in general population.

Methods: This investigation was a cross-sectional study that recruited 4,885 community-dwelling residents from Zhejiang Province in September 2023 to November 2023. The logistic regression and penalized spline method were applicated to determine the correlation between RFM with prehypertension and hypertension. The interaction effects and subgroups analyses were further conducted to estimate the stability of the aforesaid findings. Besides, the category-free analysis was performed to demonstrate whether the addition of the RFM levels to the traditional model could improve the risk classification of prehypertension and hypertension.

Results: The prevalence of prehypertension and hypertension were, respectively, 64.8%. Multivariable logistic regression indicated that the risk of prehypertension (hazard ratio, 1.99; 95% confidence interval, 1.63-2.44) and hypertension (3.41; 2.81-4.14), respectively, increased by 99% and 241% per standard deviation increase in RFM after adjusting for established risk factors. Taking the participants in the lowest RFM quartile as the reference, and those with the highest quartile had a significantly increased risk of prehypertension (5.26; 3.03-9.12) and hypertension (20.42; 11.84-35.22). The restricted cubic splines demonstrated aforesaid associations were linear, and interaction and subgroup analysis observed the stability of these findings. The category-free analysis suggested that the addition of RFM to the traditional model eventuated an improvement in predictive ability of prehypertension and hypertension.

Conclusions: Our results corroborated the positive association between RFM with prehypertension and hypertension. Clinically, the calculation of RFM should be emphasized in the risk assessment of hypertension and prehypertension.

目的:探讨普通人群相对脂肪量(RFM)与高血压前期和高血压的关系。方法:采用横断面研究方法,于2023年9月至2023年11月在浙江省社区居民中抽取4885人进行调查。应用logistic回归和惩罚样条法确定RFM与高血压前期和高血压的相关性。进一步进行相互作用效应和亚组分析,以评估上述结果的稳定性。此外,通过无类别分析验证在传统模型中加入RFM水平是否可以改善高血压前期和高血压的风险分类。结果:高血压前期和高血压患病率分别为64.8%。多变量logistic回归显示,高血压前期风险(风险比,1.99;95%可信区间,1.63-2.44)和高血压(3.41;2.81-4.14),在调整确定的危险因素后,RFM的每标准差增加分别增加99%和241%。以RFM最低四分位数的参与者为参照,最高四分位数的参与者高血压前期风险显著增加(5.26;3.03-9.12)和高血压(20.42;11.84 - -35.22)。限制三次样条表明上述关联是线性的,相互作用和亚群分析观察到这些发现的稳定性。无分类分析表明,在传统模型中加入RFM后,高血压前期和高血压的预测能力有所提高。结论:我们的研究结果证实了RFM与高血压前期和高血压之间的正相关。临床上,在高血压及高血压前期的风险评估中,应重视RFM的计算。
{"title":"Significance of relative fat mass to estimate prevalent prehypertension and hypertension in the general population.","authors":"Shan Li, Zhi Du, Heng Chen, Liding Zhao, Pei Zhou, Xuan Zhang, Safraz Anwar, Jialan Lv, Zhicheng Pan, Xiaogang Guo","doi":"10.1080/00325481.2025.2502317","DOIUrl":"10.1080/00325481.2025.2502317","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the relationship between relative fat mass (RFM) with prehypertension and hypertension in general population.</p><p><strong>Methods: </strong>This investigation was a cross-sectional study that recruited 4,885 community-dwelling residents from Zhejiang Province in September 2023 to November 2023. The logistic regression and penalized spline method were applicated to determine the correlation between RFM with prehypertension and hypertension. The interaction effects and subgroups analyses were further conducted to estimate the stability of the aforesaid findings. Besides, the category-free analysis was performed to demonstrate whether the addition of the RFM levels to the traditional model could improve the risk classification of prehypertension and hypertension.</p><p><strong>Results: </strong>The prevalence of prehypertension and hypertension were, respectively, 64.8%. Multivariable logistic regression indicated that the risk of prehypertension (hazard ratio, 1.99; 95% confidence interval, 1.63-2.44) and hypertension (3.41; 2.81-4.14), respectively, increased by 99% and 241% per standard deviation increase in RFM after adjusting for established risk factors. Taking the participants in the lowest RFM quartile as the reference, and those with the highest quartile had a significantly increased risk of prehypertension (5.26; 3.03-9.12) and hypertension (20.42; 11.84-35.22). The restricted cubic splines demonstrated aforesaid associations were linear, and interaction and subgroup analysis observed the stability of these findings. The category-free analysis suggested that the addition of RFM to the traditional model eventuated an improvement in predictive ability of prehypertension and hypertension.</p><p><strong>Conclusions: </strong>Our results corroborated the positive association between RFM with prehypertension and hypertension. Clinically, the calculation of RFM should be emphasized in the risk assessment of hypertension and prehypertension.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"408-415"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
All-cause mortality among primary care patients with type 2 diabetes: a prospective cohort study. 2型糖尿病初级保健患者的全因死亡率:一项前瞻性队列研究
Pub Date : 2025-06-01 Epub Date: 2025-05-29 DOI: 10.1080/00325481.2025.2510709
David Martín-Enguix, Juan Carlos Aguirre Rodríguez, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, María Nieves Generoso Torres, María Guisasola Cárdenas, Alicia González Bravo, Carl J Lavie, Francisco J Amaro-Gahete

Objectives: This research aimed to investigate the factors contributing to mortality in patients with type 2 diabetes (T2D) to identify the primary determinants that exacerbate mortality risks in this population.

Methods: In this cohort study, 297 T2D patients from an urban Spanish population were monitored over 49 months to assess survival. The study collected sociodemographic and clinical data, including cardiovascular risk factors and initial treatments, to examine their impact on patient survival.

Results: Of the initial 291 T2D patients, 60.1% were over 65y, with a male majority (53.3%) and average T2D duration of 8.8 years. In the 4-year follow-up, 15.4% of the patients died, predominantly due to cardiovascular disease (33.3%) and cancer (31.1%). In multivariate analysis, age (Hazard Ratio [HR] 1.169, p = 0.002) and body mass index (BMI; HR 0.807, p = 0.039) were identified as potential modulators of such relationships.

Conclusion: The present study reveals that cardiovascular disease, closely followed by cancer, are the leading causes of mortality in a Spanish T2D patients' cohort over a 4-year follow-up. In addition to age - which, as expected, was clearly associated with higher mortality - BMI was inversely associated with mortality, supporting the existence of an obesity paradox in T2D.

目的:本研究旨在调查导致2型糖尿病(T2D)患者死亡的因素,以确定加剧该人群死亡风险的主要决定因素。方法:在这项队列研究中,来自西班牙城市人群的297例T2D患者被监测了49个月,以评估生存率。该研究收集了社会人口学和临床数据,包括心血管危险因素和初始治疗,以检查它们对患者生存的影响。结果:291例T2D患者中,65岁以上患者占60.1%,男性居多(53.3%),T2D平均病程8.8年。在4年的随访中,15.4%的患者死亡,主要原因是心血管疾病(33.3%)和癌症(31.1%)。多因素分析中,年龄(危险比[HR] 1.169, p = 0.002)、体重指数(BMI;HR 0.807, p = 0.039)被认为是这种关系的潜在调节因子。结论:目前的研究表明,心血管疾病,紧随其后的是癌症,是西班牙t2dm患者4年随访期间的主要死亡原因。除了年龄(正如预期的那样,年龄明显与较高的死亡率相关)之外,BMI与死亡率呈负相关,这支持了肥胖悖论在t2dm中的存在。
{"title":"All-cause mortality among primary care patients with type 2 diabetes: a prospective cohort study.","authors":"David Martín-Enguix, Juan Carlos Aguirre Rodríguez, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, María Nieves Generoso Torres, María Guisasola Cárdenas, Alicia González Bravo, Carl J Lavie, Francisco J Amaro-Gahete","doi":"10.1080/00325481.2025.2510709","DOIUrl":"10.1080/00325481.2025.2510709","url":null,"abstract":"<p><strong>Objectives: </strong>This research aimed to investigate the factors contributing to mortality in patients with type 2 diabetes (T2D) to identify the primary determinants that exacerbate mortality risks in this population.</p><p><strong>Methods: </strong>In this cohort study, 297 T2D patients from an urban Spanish population were monitored over 49 months to assess survival. The study collected sociodemographic and clinical data, including cardiovascular risk factors and initial treatments, to examine their impact on patient survival.</p><p><strong>Results: </strong>Of the initial 291 T2D patients, 60.1% were over 65y, with a male majority (53.3%) and average T2D duration of 8.8 years. In the 4-year follow-up, 15.4% of the patients died, predominantly due to cardiovascular disease (33.3%) and cancer (31.1%). In multivariate analysis, age (Hazard Ratio [HR] 1.169, <i>p</i> = 0.002) and body mass index (BMI; HR 0.807, <i>p</i> = 0.039) were identified as potential modulators of such relationships.</p><p><strong>Conclusion: </strong>The present study reveals that cardiovascular disease, closely followed by cancer, are the leading causes of mortality in a Spanish T2D patients' cohort over a 4-year follow-up. In addition to age - which, as expected, was clearly associated with higher mortality - BMI was inversely associated with mortality, supporting the existence of an obesity paradox in T2D.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"359-367"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144129871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking the diagnostic potential of parathormone washout: a path to accurate parathyroid tumor localization. 解锁甲状旁腺激素冲洗的诊断潜力:准确定位甲状旁腺肿瘤的途径。
Pub Date : 2025-06-01 Epub Date: 2025-05-19 DOI: 10.1080/00325481.2025.2506983
Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Belma Tural Balsak, Mustafa Ömer Yazicioğlu, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir

Objective: Accurate tumor localization is necessary for the application of minimally invasive surgery, which is preferred in the treatment of primary hyperparathyroidism. Parathormone-washout (PTH-WO) is parathyroid fine-needle aspiration followed by PTH measurement in the needle washout fluid. This study aimed to determine appropriate cutoff values for the PTH-WO method.

Methods: A total of 402 PTH-WO assays from 339 patients were included in the study. The diagnostic accuracy of the test was assessed by accepting as a positive result a PTH-WO result higher than the serum PTH level [PTH-WO/serum PTH(PTH ratio)>1]. In addition, a cutoff value for the test was established by evaluating the PTH washout results obtained in comparison with postoperative histopathology. Undiluted test results were not included to obtain a clear numerical value in this evaluation. The results of parathyroid scintigraphy and fine needle aspiration biopsy (FNAB) were compared with postoperative histopathology.

Results: While 309 (76.86%) of the PTH-WO procedures were considered positive, 93 (23.13%) were considered negative if the PTH ratio was > 1. When these results were compared with the postoperative histopathology, the test's sensitivity was 92.51%, and the specificity was 100.00%. In the analysis of the remaining 292 PTH-WO samples after excluding the undiluted ones, the sensitivity and specificity of the method were 92.3% and 94.1%, respectively, with a PTH ratio > 0.99. With a cutoff value of 99.5 ng/l for PTH-WO value, 93.1% sensitivity and 94.3% specificity were obtained. The sensitivities of parathyroid scintigraphy and FNAB were 53.4% and 15.3%, respectively.

Conclusions: The PTH-WO method is safe and cheap, with high sensitivity and specificity in localizing parathyroid tumor. In cases where radiological methods cannot achieve localization with specified cutoff values, it has high diagnostic accuracy.

目的:准确的肿瘤定位是微创手术应用的必要条件,是治疗原发性甲状旁腺功能亢进的首选方法。甲状旁腺激素冲洗(PTH- wo)是甲状旁腺细针抽吸,然后在针冲洗液中测量甲状旁腺激素。本研究旨在为PTH-WO方法确定合适的截止值。方法:对339例患者进行402项PTH-WO测定。将PTH- wo结果高于血清PTH水平(PTH - wo /血清PTH(PTH比值)>1)视为阳性结果来评估该试验的诊断准确性。此外,通过评估PTH冲洗结果与术后组织病理学比较,建立了该试验的截止值。未稀释的试验结果不包括在内,以便在本评价中获得明确的数值。将甲状旁腺显像和细针穿刺活检(FNAB)结果与术后组织病理学进行比较。结果:PTH- wo检查阳性309例(76.86%),阴性93例(23.13%)。将这些结果与术后组织病理学进行比较,该试验的敏感性为92.51%,特异性为100.00%。在剔除未稀释标本后剩余292份PTH- wo标本的分析中,该方法的灵敏度和特异性分别为92.3%和94.1%,PTH比值为bb0 0.99。PTH-WO值的截止值为99.5 ng/l,灵敏度为93.1%,特异性为94.3%。甲状旁腺闪烁成像和FNAB的敏感性分别为53.4%和15.3%。结论:PTH-WO法对甲状旁腺肿瘤的定位具有较高的敏感性和特异性,安全、廉价。在某些情况下,放射学方法不能达到特定的截止值定位,它具有很高的诊断准确性。
{"title":"Unlocking the diagnostic potential of parathormone washout: a path to accurate parathyroid tumor localization.","authors":"Ekin Yiğit Köroğlu, Berna Evranos Öğmen, Belma Tural Balsak, Mustafa Ömer Yazicioğlu, Cevdet Aydin, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir","doi":"10.1080/00325481.2025.2506983","DOIUrl":"10.1080/00325481.2025.2506983","url":null,"abstract":"<p><strong>Objective: </strong>Accurate tumor localization is necessary for the application of minimally invasive surgery, which is preferred in the treatment of primary hyperparathyroidism. Parathormone-washout (PTH-WO) is parathyroid fine-needle aspiration followed by PTH measurement in the needle washout fluid. This study aimed to determine appropriate cutoff values for the PTH-WO method.</p><p><strong>Methods: </strong>A total of 402 PTH-WO assays from 339 patients were included in the study. The diagnostic accuracy of the test was assessed by accepting as a positive result a PTH-WO result higher than the serum PTH level [PTH-WO/serum PTH(PTH ratio)>1]. In addition, a cutoff value for the test was established by evaluating the PTH washout results obtained in comparison with postoperative histopathology. Undiluted test results were not included to obtain a clear numerical value in this evaluation. The results of parathyroid scintigraphy and fine needle aspiration biopsy (FNAB) were compared with postoperative histopathology.</p><p><strong>Results: </strong>While 309 (76.86%) of the PTH-WO procedures were considered positive, 93 (23.13%) were considered negative if the PTH ratio was > 1. When these results were compared with the postoperative histopathology, the test's sensitivity was 92.51%, and the specificity was 100.00%. In the analysis of the remaining 292 PTH-WO samples after excluding the undiluted ones, the sensitivity and specificity of the method were 92.3% and 94.1%, respectively, with a PTH ratio > 0.99. With a cutoff value of 99.5 ng/l for PTH-WO value, 93.1% sensitivity and 94.3% specificity were obtained. The sensitivities of parathyroid scintigraphy and FNAB were 53.4% and 15.3%, respectively.</p><p><strong>Conclusions: </strong>The PTH-WO method is safe and cheap, with high sensitivity and specificity in localizing parathyroid tumor. In cases where radiological methods cannot achieve localization with specified cutoff values, it has high diagnostic accuracy.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"439-446"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the 'Diabetes Paradox' in Takotsubo Cardiomyopathy. 研究Takotsubo心肌病的“糖尿病悖论”。
Pub Date : 2025-06-01 Epub Date: 2025-05-07 DOI: 10.1080/00325481.2025.2502315
Song Peng Ang, Jia Ee Chia, Kwan Lee, Madhan Shanmugasundaram, Abhishek J Deshmukh, Chayakrit Krittanawong, Jose Iglesias, Debabrata Mukherjee, Carl J Lavie

Background: The impact of diabetes mellitus (DM) on outcomes of Takotsubo cardiomyopathy (TC) remains unclear, with conflicting evidence suggesting either protective or harmful effects. This study evaluates the association between DM and in-hospital outcomes in TC patients.

Methods: A retrospective analysis of the National Inpatient Sample database (2016-2019) was conducted to compare in-hospital outcomes in TC patients with and without DM. The primary outcome was in-hospital mortality, while secondary outcomes included cardiac arrest, cardiogenic shock, and acute kidney injury (AKI). Propensity-score matching (PSM) was applied to balance covariates, and multivariable logistic regression was used to evaluate DM as an independent predictor of mortality, with results reported as adjusted odds ratios (ORs) and 95% confidence intervals (CIs).

Results: Of 63,155 TC hospitalizations 13,380 (21.2%) involved patients with DM, who were older and had higher rates of comorbidities. PSM analysis revealed a higher risk of AKI in DM patients (20.13% vs. 15.91%; OR, 1.33; 95% CI, 1.16-1.54; p < 0.001), with no significant differences in mortality, cardiogenic shock, or cardiac arrest. Patients with diabetic neuropathy showed a non-significant trend toward increased AKI risk (27.04% vs. 20.44%; OR, 1.44; 95% CI, 1.00-2.09; p = 0.053). Multivariable analysis identified comorbidities like CKD, liver disease, and coagulopathy as mortality predictors, but not DM.

Conclusion: DM was associated with a higher risk of AKI but did not affect in-hospital mortality or major cardiac events in TC patients. These findings suggest that DM has a neutral impact on TC outcomes, highlighting the need for further investigation.

背景:糖尿病(DM)对Takotsubo心肌病(TC)预后的影响尚不清楚,有相互矛盾的证据表明其有保护作用或有害作用。本研究评估糖尿病与TC患者住院预后之间的关系。方法:对2016-2019年全国住院患者样本数据库进行回顾性分析,比较合并和不合并DM的TC患者的住院结局。主要结局是院内死亡率,次要结局包括心脏骤停、心源性休克和急性肾损伤(AKI)。使用倾向评分匹配(PSM)来平衡协变量,并使用多变量逻辑回归来评估DM作为死亡率的独立预测因子,结果以调整优势比(ORs)和95%置信区间(CIs)报告。结果:在63155例TC住院患者中,13380例(21.2%)涉及糖尿病患者,这些患者年龄较大,合并症发生率较高。PSM分析显示DM患者AKI的风险更高(20.13% vs. 15.91%;或者,1.33;95% ci, 1.16-1.54;p = 0.053)。多变量分析发现CKD、肝脏疾病和凝血功能障碍等合并症是死亡率的预测因素,但DM不是。结论:DM与AKI的高风险相关,但不影响TC患者的住院死亡率或主要心脏事件。这些发现表明DM对TC结果的影响是中性的,强调了进一步研究的必要性。
{"title":"Investigating the 'Diabetes Paradox' in Takotsubo Cardiomyopathy.","authors":"Song Peng Ang, Jia Ee Chia, Kwan Lee, Madhan Shanmugasundaram, Abhishek J Deshmukh, Chayakrit Krittanawong, Jose Iglesias, Debabrata Mukherjee, Carl J Lavie","doi":"10.1080/00325481.2025.2502315","DOIUrl":"10.1080/00325481.2025.2502315","url":null,"abstract":"<p><strong>Background: </strong>The impact of diabetes mellitus (DM) on outcomes of Takotsubo cardiomyopathy (TC) remains unclear, with conflicting evidence suggesting either protective or harmful effects. This study evaluates the association between DM and in-hospital outcomes in TC patients.</p><p><strong>Methods: </strong>A retrospective analysis of the National Inpatient Sample database (2016-2019) was conducted to compare in-hospital outcomes in TC patients with and without DM. The primary outcome was in-hospital mortality, while secondary outcomes included cardiac arrest, cardiogenic shock, and acute kidney injury (AKI). Propensity-score matching (PSM) was applied to balance covariates, and multivariable logistic regression was used to evaluate DM as an independent predictor of mortality, with results reported as adjusted odds ratios (ORs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>Of 63,155 TC hospitalizations 13,380 (21.2%) involved patients with DM, who were older and had higher rates of comorbidities. PSM analysis revealed a higher risk of AKI in DM patients (20.13% vs. 15.91%; OR, 1.33; 95% CI, 1.16-1.54; <i>p</i> < 0.001), with no significant differences in mortality, cardiogenic shock, or cardiac arrest. Patients with diabetic neuropathy showed a non-significant trend toward increased AKI risk (27.04% vs. 20.44%; OR, 1.44; 95% CI, 1.00-2.09; <i>p</i> = 0.053). Multivariable analysis identified comorbidities like CKD, liver disease, and coagulopathy as mortality predictors, but not DM.</p><p><strong>Conclusion: </strong>DM was associated with a higher risk of AKI but did not affect in-hospital mortality or major cardiac events in TC patients. These findings suggest that DM has a neutral impact on TC outcomes, highlighting the need for further investigation.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"352-358"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive review of inpatient heart failure management for the hospitalist. 住院医师对住院心力衰竭管理的全面回顾。
Pub Date : 2025-06-01 Epub Date: 2025-05-14 DOI: 10.1080/00325481.2025.2503696
Athul Rajesh, Ryan Kovacik, Beman Wasef, Kristin Lohr, Eric Kasprowicz

Acute decompensated heart failure (ADHF) is a leading cause of hospital admissions and is associated with significant increases in morbidity and mortality, as well as marked impacts on quality of life. This review aims to guide hospital medicine providers in the management of ADHF from hospital admission to safe discharge. Hospitalists commonly care for HF patients in the acute phase, and a clear understanding of HF classification and etiologies is vital for guiding the evaluation and treatment of HF decompensation. Medical management of HF is centered around guideline-directed medical therapy (GDMT), agents which have been shown in large-scale studies to improve morbidity and mortality, while diuretics are used in adjunct to alleviate symptoms and improve volume status. As patients approach discharge, a multidisciplinary approach centering on patient education, counseling, and coordination of transitional care services can help to improve outcomes and reduce readmission risk.

急性失代偿性心力衰竭(ADHF)是入院最常见的原因之一,随着全国范围内HF患病率的增加,医院将在未来几年照顾更多的患者。本综述旨在为ADHF患者从入院到出院的管理提供全面的指导。ADHF与HF患者发病率和死亡率的显著增加以及对其生活质量的显著影响相关。此外,与ADHF入院相关的医疗费用巨大。医院通常在急性期护理HF患者,清楚了解HF的分类和病因对于指导新发HF的诊断评估和正确治疗HF失代偿至关重要。住院病人评估和适当的实验室和影像学研究解释是必要的风险分层,监测,并开始循证治疗。ADHF管理的基石是指导药物治疗(GDMT),已在大规模研究中显示可改善总体发病率和死亡率。辅助使用利尿剂治疗以改善症状和容量状况。伴有低血压的不稳定ADHF患者需要仔细评估心源性休克的发展,这需要使用肌力和/或血管加压药物支持。对于即将出院的病情稳定的患者,应采取多学科的方法,包括广泛的患者咨询和教育,以及安排过渡护理服务。晚期心衰患者可以受益于适当的姑息治疗服务,以提高生活质量。
{"title":"A comprehensive review of inpatient heart failure management for the hospitalist.","authors":"Athul Rajesh, Ryan Kovacik, Beman Wasef, Kristin Lohr, Eric Kasprowicz","doi":"10.1080/00325481.2025.2503696","DOIUrl":"10.1080/00325481.2025.2503696","url":null,"abstract":"<p><p>Acute decompensated heart failure (ADHF) is a leading cause of hospital admissions and is associated with significant increases in morbidity and mortality, as well as marked impacts on quality of life. This review aims to guide hospital medicine providers in the management of ADHF from hospital admission to safe discharge. Hospitalists commonly care for HF patients in the acute phase, and a clear understanding of HF classification and etiologies is vital for guiding the evaluation and treatment of HF decompensation. Medical management of HF is centered around guideline-directed medical therapy (GDMT), agents which have been shown in large-scale studies to improve morbidity and mortality, while diuretics are used in adjunct to alleviate symptoms and improve volume status. As patients approach discharge, a multidisciplinary approach centering on patient education, counseling, and coordination of transitional care services can help to improve outcomes and reduce readmission risk.</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"327-337"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144061723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of peanut ball use on labor memory, labor satisfaction, delivery length, and neonatal APGAR score: a randomized controlled trial. 使用花生球对分娩记忆、分娩满意度、分娩时间和新生儿APGAR评分的影响:一项随机对照试验。
IF 2.8 Pub Date : 2025-06-01 Epub Date: 2025-05-26 DOI: 10.1080/00325481.2025.2510198
Seyhan Çankaya, Hacer Alan Dikmen, Ayşenur Ataş

Objectives: The purpose of this study was to evaluate the effect of using peanut balls during labor-on-labor memory, labor satisfaction, labor length, and neonatal APGAR scores.

Methods: This randomized, controlled, single-blind trial was conducted in 140 primiparous pregnant women (peanut ball group n = 70, control group n = 70) who delivered between January 2023 and March 2024. The study was conducted in the Obstetrics Clinic of a Medical Faculty Hospital in the Central Anatolian region of Turkey. Pregnant women in the peanut ball group were instructed to perform movements with the peanut ball after cervical dilation reached 5 cm. The control group received only standard intrapartum midwifery care. Data were collected by personal information form, labor and postpartum follow-up form (APGAR score, etc.), Birth Memory and Recall Scale, and Birth Satisfaction Scales.

Results: It was determined that the birth memory and recall memories of the pregnant women in the peanut ball group were more positive and their birth satisfaction was higher than the pregnant women in the control group (p < 0.001). The 1st minute APGAR scores (8.3 ± 0.6) and 5th minute APGAR scores (9.2 ± 0.7) of the newborns of the peanut ball group were higher than the 1st minute APGAR scores (7.8 ± 0.7) and 5th minute APGAR scores (8.5 ± 0.7) of the newborns of the control group (p < 0.001). The duration of the first stage (209.3 ± 38.6) and second stage (27.4 ± 13.7) of labor in the peanut ball group was shorter than the duration of the first stage (250.3 ± 54.6) and second stage (32.3 ± 11.3) of labor in the control group (p < 0.001, p = 0.021, respectively).

Conclusion: This study found that peanut ball application positively affected women's labor memory and recall, and increased labor satisfaction. In addition, we found that peanut ball application increased neonatal APGAR scores and shortened the duration of the first and second stages of labor.

Clinical trial registration: www.clinicaltrials.gov (NCT06387680).

目的:本研究的目的是评估花生球对产程记忆、产程满意度、产程长度和新生儿APGAR评分的影响。方法:本研究采用随机、对照、单盲方法,选取2023年1月至2024年3月间分娩的140例初产孕妇(花生球组70例,对照组70例)为研究对象。这项研究是在土耳其中部安纳托利亚地区一所医学院医院的产科诊所进行的。花生球组孕妇在宫颈扩张达到5厘米后,指导孕妇用花生球进行运动。对照组只接受标准的产时助产护理。采用个人信息表、产程及产后随访表(APGAR评分等)、分娩记忆与回忆量表、分娩满意度量表收集数据。结果:花生球组孕妇的出生记忆和回忆记忆较对照组孕妇更积极,分娩满意度高于对照组(p p p p = 0.021)。结论:本研究发现花生球应用对产妇的劳动记忆和回忆有积极的影响,提高了产妇的劳动满意度。此外,我们发现花生球应用增加新生儿APGAR评分,缩短第一和第二产程的持续时间。临床试验注册:www.clinicaltrials.gov (NCT06387680)。
{"title":"The effect of peanut ball use on labor memory, labor satisfaction, delivery length, and neonatal APGAR score: a randomized controlled trial.","authors":"Seyhan Çankaya, Hacer Alan Dikmen, Ayşenur Ataş","doi":"10.1080/00325481.2025.2510198","DOIUrl":"10.1080/00325481.2025.2510198","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to evaluate the effect of using peanut balls during labor-on-labor memory, labor satisfaction, labor length, and neonatal APGAR scores.</p><p><strong>Methods: </strong>This randomized, controlled, single-blind trial was conducted in 140 primiparous pregnant women (peanut ball group <i>n</i> = 70, control group <i>n</i> = 70) who delivered between January 2023 and March 2024. The study was conducted in the Obstetrics Clinic of a Medical Faculty Hospital in the Central Anatolian region of Turkey. Pregnant women in the peanut ball group were instructed to perform movements with the peanut ball after cervical dilation reached 5 cm. The control group received only standard intrapartum midwifery care. Data were collected by personal information form, labor and postpartum follow-up form (APGAR score, etc.), Birth Memory and Recall Scale, and Birth Satisfaction Scales.</p><p><strong>Results: </strong>It was determined that the birth memory and recall memories of the pregnant women in the peanut ball group were more positive and their birth satisfaction was higher than the pregnant women in the control group (<i>p</i> < 0.001). The 1st minute APGAR scores (8.3 ± 0.6) and 5th minute APGAR scores (9.2 ± 0.7) of the newborns of the peanut ball group were higher than the 1st minute APGAR scores (7.8 ± 0.7) and 5th minute APGAR scores (8.5 ± 0.7) of the newborns of the control group (<i>p</i> < 0.001). The duration of the first stage (209.3 ± 38.6) and second stage (27.4 ± 13.7) of labor in the peanut ball group was shorter than the duration of the first stage (250.3 ± 54.6) and second stage (32.3 ± 11.3) of labor in the control group (<i>p</i> < 0.001, <i>p</i> = 0.021, respectively).</p><p><strong>Conclusion: </strong>This study found that peanut ball application positively affected women's labor memory and recall, and increased labor satisfaction. In addition, we found that peanut ball application increased neonatal APGAR scores and shortened the duration of the first and second stages of labor.</p><p><strong>Clinical trial registration: </strong>www.clinicaltrials.gov (NCT06387680).</p>","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"368-378"},"PeriodicalIF":2.8,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144113151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts from the 19th Annual Cardiometabolic Health Congress. 第19届年度心脏代谢健康大会摘要
Pub Date : 2025-04-21 Epub Date: 2025-04-01 DOI: 10.1080/00325481.2025.2476828
{"title":"Abstracts from the 19th Annual Cardiometabolic Health Congress.","authors":"","doi":"10.1080/00325481.2025.2476828","DOIUrl":"10.1080/00325481.2025.2476828","url":null,"abstract":"","PeriodicalId":94176,"journal":{"name":"Postgraduate medicine","volume":" ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Postgraduate medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1